BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Artificial Intelligence

Lunit Partners with SITC to Launch AI-Powered Research Program for Cancer Immunotherapy

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has entered into a partnership with the Society ...

February 04, 2025 | News

Cognizant and Medidata Expand AI-Driven Partnership to Advance Clinical Trials

The organizations plan to support clients through expanded partnership and offer broader access to Medidata's AI-powered technologies to accelerate clinica...

January 31, 2025 | News

Ryght AI and Cancer Research South Australia Partner to Accelerate Cancer Clinical Trials in Australia with AI

Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, and Cancer Research South Australia (CRSA), a premier...

January 29, 2025 | News

SOPHiA GENETICS Launches OncoPortal™ Mutation Tracker to Elevate Longitudinal MRD Monitoring in Oncology

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has unveiled the OncoPortal&...

January 29, 2025 | News

Australia’s Inventia Life Science Launches RASTRUM™ Allegro to Transform 3D Cell Culture Research

Inventia Life Science has announced the release of RASTRUM™ Allegro, a new development in 3D cell culture technology aimed at addressing challenges i...

January 28, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Menarini Group Partners with Insilico Medicine on AI-Discovered Oncology Asset in $550M Licensing Deal

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, si...

January 13, 2025 | News

NEC and Biomy Partner to Advance AI-Powered Digital Pathology for Precision Cancer Care

NEC Corporation (NEC; TSE: 6701) and Biomy, Inc. (Biomy) have signed a Memorandum of Understanding (MoU) to form a joint marketing partnership aimed at adv...

January 10, 2025 | News

Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development

In an exclusive interview with BioPharma APAC, Heather Hargett, Head of Cell Biology Reagents & Tools at MilliporeSigma ( Merck KGaA, Darmstadt, German...

January 10, 2025 | News

Leica Biosystems Partners with Indica Labs to Transform AI-Driven Digital Pathology

Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine par...

January 09, 2025 | News

Insilico Medicine Reports Positive Phase I Results for ISM5411, Advancing AI-Driven IBD Treatment

Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today s...

January 08, 2025 | News

BGM Group Enters AI-Driven Healthcare and Insurance Sector with Strategic Acquisition of AIX Inc.

BGM Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM"), a leading global pharmaceutical enterprise, announced completion of the acquisition of the int...

December 30, 2024 | News

Axcelead Drug Discovery Partners Joins Forces with Astellas Pharma to Advance Targeted Protein Degrader Research

Axcelead Drug Discovery Partners, Inc. announced today that it has entered into a drug discovery service agreement with Astellas Pharma, Inc. (HQ: Ch...

December 26, 2024 | News

Stay Connected